Stockholm, Sweden — Medivir AB (OMX: MVIR) is, as previously announced, conducting a reorganisation of the company’s management group which will, as of 1 March, comprise six people, including the President & CEO. Medivir has recruited two new people in order to strengthen important functions and generate an increased operational focus. Christine Lind has been employed as the Executive Vice President, Strategic Business Development. She will have operational responsibility for the newly created Strategic Business Development function. Christine’s most recent position was as Vice President, Business Development at LifeCell Corporation in New York, and she also has twelve years of investment banking experience at Merrill Lynch & Co. and Gerard Klauer Mattison & Co. Christine studied Finance and Information Systems at New York University and also has a Master of Business Administration from Columbia Business School. Ola Burmark has been employed as the Chief Financial Officer. His areas of responsibility include not only operational responsibility for the Finance & Administration function, but also responsibility for Investor Relations. Ola’s previous positions include that of CFO at OneMed AB and Aditro Holding AB. He has also worked as SVP Finance and M&A at Thule Group AB and Cell Network AB, as Cash Manager at AB SCA Finans, and as an auditor at Ernst & Young. Ola has a B.Sc. in Finance and Business Administration. “I’m delighted to welcome Christine and Ola to Medivir. They both bring extensive experience and specialist skills that will be of huge benefit to us, now that we are accelerating our work on strategic implementation and long-term value generation within the company. I look forward to continuing this work in partnership with the new management group and other members of staff,” says Niklas Prager, President & CEO of Medivir AB. For more information please contact: Niklas Prager, CEO Medivir AB, phone +46 (0)8-407 64 30. About Medivir Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical need. Our commercial organization provides a growing portfolio of specialty care pharmaceuticals on the Nordic market. Medivir is listed on the Nasdaq Stockholm Mid Cap List.
New members of Medivir’s management group Stockholm,
Top 10 Most Recent News Articles
Central Florida Buyers Face the Cash Reality First
A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...
Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern
Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...
Continue Reading
California Stone Ban Puts a Hidden Worker Toll in View
Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....
Continue Reading
DISA Backs Nursing Education With OADN Foundation Push
A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...
Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs
Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...
Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact
A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...
Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now
A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...
Continue Reading
Minnesota Giving Record Signals a Stressed Safety Net
Thirty-eight million dollars landing in one day is no small civic heartbeat. Minnesota’s Give to the Max Day brought in a record $38.4 million in 2026 for nearly 6,000 nonprofits and schools, edging past the $37.8 million raised in 2025. More than 65,000 people gave. That deserves a clear-eyed nod, not a cynical shrug. Still, the number carries two messages at once. It...
Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet
Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...
Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors
An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...
Continue ReadingTop 5 Most Recently Viewed Articles
BlackBerry QNX and Pi Square Join Forces to Advance Indian Tech
BlackBerry QNX Partners with Pi Square Technologies BlackBerry Limited (NYSE: BB) is experiencing a notable increase in share prices, reflecting growing investor confidence. Expanding Horizons for Engineers Recently, BlackBerry’s QNX division announced an exciting multi-year collaboration with Pi Square Technologies. This initiative aims to train thousands of engineers...
Continue Reading
Investors Urged to Act: Investigating DexCom Securities Claims
Understanding the Ongoing Investigations into DexCom Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating potential claims on behalf of investors affected by losses in DexCom, Inc. (NASDAQ: DXCM). This inquiry is a direct response to significant concerns raised about the company's business practices and market performance. The Scope...
Continue Reading
Legal Battle Heats Up for Michigan Auto Attorney Over CURE
Michigan Attorney Faces Legal Challenges Amid CURE Controversy In a recent turn of events, an attorney from Michigan is experiencing the challenges of navigating legal waters after speaking out against CURE Auto Insurance. The attorney, Steven M. Gursten, along with his firm Michigan Auto Law, is embroiled in lawsuits that highlight serious concerns about consumer...
Continue Reading
Investors of Joint Stock Company Kaspi.kz (KSPI) Take Action Now
Investors of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) Take Action Attention investors of Joint Stock Company Kaspi.kz, also known as KSPI! A recent report has raised serious concerns regarding the company's activities, prompting investors who have experienced losses to consider their options in filing a securities fraud lawsuit. These troubling developments are crucial...
Continue Reading
Investors Guide: Urgent Action Needed for Western Asset Fund
Introduction to the Class Action The Rosen Law Firm, a prominent name in investor rights advocacy, is urging investors in the Western Asset Management Company mutual funds to take action before an important deadline. If you invested in the 'Western Asset US Core Bond Fund' or the 'Western Asset Core Plus Bond Fund' during the designated class period, this message is...
Continue Reading